Search research articles
Contact Us
Filters
Showing results (121-130 of 162) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
March 19, 2026
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy
Lukas H Haaksma, Tom Reuvekamp, Kasper J Croese, et al.
Blood Advances
|
May 13, 2024
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry
Mirian Brink, Francien Huisman, Frederik O Meeuwes, et al.
Haematologica
|
June 2, 2016
Severe Ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts
Timothy J Satchwell, Amanda J Bell, Bethan R Hawley, et al.
Blood
|
January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients
Gerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Science Advances
|
April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
Isabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Blood Advances
|
August 2, 2021
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
Mirian Brink, Xaver U Kahle, Joost S P Vermaat, et al.
Cancer Cell
|
September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones
Bauke de Boer, Janine Prick, Maurien G Pruis, et al.
Transplantation and Cellular Therapy
|
December 1, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8<sup>+</sup> T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
Jesper van Eck van der Sluijs, Diede van Ens, Ayla Grotens, et al.
Cell Reports. Medicine
|
January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia
Diego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Blood Neoplasia
|
April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia
Niels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 162) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
March 19, 2026
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy
Lukas H Haaksma, Tom Reuvekamp, Kasper J Croese, et al.
Blood Advances
|
May 13, 2024
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry
Mirian Brink, Francien Huisman, Frederik O Meeuwes, et al.
Haematologica
|
June 2, 2016
Severe Ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts
Timothy J Satchwell, Amanda J Bell, Bethan R Hawley, et al.
Blood
|
January 12, 2019
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients
Gerwin Huls, Dana A Chitu, Violaine Havelange, et al.
Science Advances
|
April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
Isabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Blood Advances
|
August 2, 2021
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
Mirian Brink, Xaver U Kahle, Joost S P Vermaat, et al.
Cancer Cell
|
September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones
Bauke de Boer, Janine Prick, Maurien G Pruis, et al.
Transplantation and Cellular Therapy
|
December 1, 2025
Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8<sup>+</sup> T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients
Jesper van Eck van der Sluijs, Diede van Ens, Ayla Grotens, et al.
Cell Reports. Medicine
|
January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia
Diego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Blood Neoplasia
|
April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia
Niels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Page
of 17